RubrYc Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RubrYc Therapeutics, Inc. - overview
Established
2017
Location
San Carlos, CA, US
Primary Industry
Biotechnology
About
Founded in 2017 and based in California, US, RubrYc Therapeutics, Inc. operates as a biotechnology company that develops molecular therapeutic antibodies using its proprietary machine learning and computational biology technologies.
Current Investors
Paladin Capital Group, Third Point, Vital Venture Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Verticals
Artificial Intelligence
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.